This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: C3 Biotechnologies Limited. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: The Innovations of Robin Hoeven
Introduction
Robin Hoeven is a notable inventor based in Manchester, GB. He has made significant contributions to the field of biotechnology, particularly in hydrocarbon production. His work has led to the development of innovative solutions that have the potential to impact various industries.
Latest Patents
Robin Hoeven holds a patent related to hydrocarbon production. The patent discloses a fatty acid decarboxylase that comprises at least 40% sequence identity to SEQ ID NO:1 or 2, along with an amino acid substitution at a position corresponding to G462 of SEQ ID NO:1. This invention showcases his expertise in biochemistry and its applications in sustainable energy production.
Career Highlights
Throughout his career, Robin has been associated with C3 Biotechnologies Limited, where he has played a crucial role in advancing biotechnological research and development. His innovative approach and dedication to his work have earned him recognition in the scientific community.
Collaborations
Robin Hoeven has collaborated with esteemed colleagues such as Nigel Scrutton and Helen Toogood. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research.
Conclusion
In summary, Robin Hoeven is a distinguished inventor whose work in hydrocarbon production exemplifies the intersection of biotechnology and innovation. His contributions continue to pave the way for advancements in sustainable energy solutions.